Patent · US Active

C10RF32 antibodies, and uses thereof for treatment of cancer

US9617336B2 · kind B2 · utility

11Cited by

152References

23Claims

0Family size

Assignee

Compugen Ltd. · IL

Inventors

Gady S. Cojocaru · Ramat HaSharon, IL
Galit Rotman · Herzliya, IL
Zurit Levine · Herzliya, IL
Liat Dassa · Tel Aviv-Yafo, IL
Ofer Levi · Afula, IL
Raffaella Briante · Burlingame, US
Shweta Singh · Fremont, US
Susan R. Watson · Corona, US
Tania Pergam · Rishon LeZion, IL

Key dates

Filing date	Jan 31, 2013
Grant date	Apr 11, 2017
Priority date	—
Expiry date	Apr 18, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70503
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.